Loic Ysebaert

9PUBLICATIONS
22CO-AUTHORS
AutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2025
Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Yoann Zadro, Amélie Lusque, Héloïse Rey

|Nov 01, 2024
Ibrutinib-related stellar hematomas of the palms and soles.

Naia Oillarburu, Loic Ysebaert, Caroline Protin

|Jun 21, 2021
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).

Grégory Lazarian, Michaël Munger, Anne Quinquenel

|Apr 05, 2019
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group.

Anne Quinquenel, Sophie Godet, Caroline Dartigeas

|Jun 10, 2018
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.

Cédric Rossi, Julia Gilhodes, Marie Maerevoet

|Nov 24, 2017
Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.

David Ribes, Hélène E L Hachem, Lucie Oberic

Pageof 2

Frequent Collaborators

3 joint publications

Anne Quinquenel

2 joint publications

Anne-Sophie Michallet

2 joint publications

Damien Roos-Weil

1 joint publications

Stanislas Faguer